Last updated on September 2020

A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)


Brief description of study

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

Clinical Study Identifier: NCT04437511

Find a site near you

Start Over

Pacific Research Network Inc

San Diego, CA United States
2.38miles
  Connect »

Pacific Research Network

San Diego, CA United States
2.38miles
  Connect »

Sharp Mesa Vista Hospital

San Diego, CA United States
6.74miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.